|

Prasugrel/Ticagrelor monotherapy or aspirin plus clopidogrel Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • University of Florida1

Indications

  • Coronary Arterial Disease (CAD)1
  • Heart Disease1

Jacksonville, Florida1 trial

The Switching Antiplatelet-9 (SWAP-9) Study

University of Florida

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.